Review Note
Last Update: 08/30/2023 12:42 AM
Current Deck: ACMS Study Guide Deck::A. Cancers
PublishedCurrently Published Content
Front
Do you have a higher or lower risk of recurrence if oncoprotein antibody negative in MCC?
Back
Among MCPyV oncoprotein antibody seropositive patients, titer
correlates with tumor burden
▪ Rising titers can suggest recurrence
▪ Patients with oncoprotein antibody seronegative at diagnosis had
significantly (42%) higher risk of recurrence, and may benefit from
more intensive surveillance
correlates with tumor burden
▪ Rising titers can suggest recurrence
▪ Patients with oncoprotein antibody seronegative at diagnosis had
significantly (42%) higher risk of recurrence, and may benefit from
more intensive surveillance
Current Tags:
Pending Suggestions
No pending suggestions for this note.